What it sells
Develops biochemical flotation reagents for copper mining that aim to improve mineral selectivity and recovery within existing flotation circuits.
Business model breakdown
Workflow: what inputs become what output?
Replaces/optimizes reagents in the copper flotation circuit, validated against current reagents on real ore at lab scale.
Economics: what it saves and how it charges
Reports +3-5 percentage points copper recovery uplift in lab-scale tests (not universal).
Distribution: how it reaches customers
Consultative pilot process: prospects email ore and circuit details, then Giraffe Bio characterizes samples and runs lab-scale validation.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-15 | Seed | $6.4M | — | news.google.com |
| 2026-10-15 | Seed | $6.4M | — | news.google.com |
| 2026-10-13 | — | $6.4M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-17.